<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17608">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877667</url>
  </required_header>
  <id_info>
    <org_study_id>Soliton 2016-001</org_study_id>
    <nct_id>NCT02877667</nct_id>
  </id_info>
  <brief_title>Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol</brief_title>
  <acronym>SOL1601</acronym>
  <official_title>Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soliton</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MedSource</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Soliton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A non-significant risk, single center, prospective device trial to evaluate the number of
      passes of Q-Switch laser treatment that can be completed with a Q-Switch Laser alone
      compared to use of the Soliton Planar Acoustic Wave Device System (AWD) System as an
      accessory to Q-switched laser in tattoo reduction treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate number of passes of laser treatment completed with Q-Switch Laser alone compared to Soliton Planar Acoustic Wave Device System (AWD) as accessory to laser</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tattoo fading by visual assessment.</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Tattoo</condition>
  <arm_group>
    <arm_group_label>Open label device treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to four passes with Q-Switched laser alternating with acoustic wave device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>planar acoustic wave device</intervention_name>
    <description>accessory to laser treatment</description>
    <arm_group_label>Open label device treatment</arm_group_label>
    <other_name>AWD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Range of Fitzpatrick skin color scores I to III

          -  Tattoo with location on arms, legs, and torso only, and accessible to AWD treatment
             head. Black ink only. Other ink colors may be present, but areas of black only tattoo
             should meet criteria described as: minimum 1&quot; x 3&quot; tattoo with at least 30-50%
             consistent coverage (see fig 1).

          -  Tattoo age between 1 and 20 years.

          -  Professionally applied.

        Exclusion Criteria:

          -  Subject is pregnant or planning to become pregnant during the duration of the study.

          -  Prior tattoo removal procedures on target tattoo.

          -  Self-applied or amateur tattoo.

          -  Tattoo layering (additional tattoo placed over an older tattoo to hide it) on target
             tattoo.

          -  Metal or plastic implants in the area of the tattoo (pacemaker, implanted
             defibrillator, stent, or implants in the hips, knees, elbows, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Capelli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Soliton</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stuart Byham</last_name>
    <phone>(919) 741-5266</phone>
    <email>sbyham@medsource.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leslie Honda</last_name>
    <phone>(206) 375-8586</phone>
    <email>lhonda@soliton.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SkinCare Physicians</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Petrell</last_name>
      <phone>617-848-1638</phone>
      <email>kpetrell@skincarephysicians.net</email>
    </contact>
    <contact_backup>
      <last_name>Joaninha Depina</last_name>
      <phone>(617) 848-1641</phone>
      <email>jdepina@skincarephysicians.com</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Kaminer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>April 6, 2017</lastchanged_date>
  <firstreceived_date>August 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tattoo</keyword>
  <keyword>laser</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
